Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection

Malaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. b...

Full description

Bibliographic Details
Main Authors: Adriana Temporão, Margarida Sanches-Vaz, Rafael Luís, Helena Nunes-Cabaço, Terry K. Smith, Miguel Prudêncio, Luisa M. Figueiredo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580256/?tool=EBI
_version_ 1818927588689575936
author Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
author_facet Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
author_sort Adriana Temporão
collection DOAJ
description Malaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. berghei liver infection and decreases malaria severity in mice. However, whether this effect requires an active trypanosome infection remained unknown. Here, we show that Plasmodium liver infection can also be inhibited by the serum of a mouse previously infected by T. brucei and by total protein lysates of this kinetoplastid. Biochemical characterisation showed that the anti-Plasmodium activity of the total T. brucei lysates depends on its protein fraction, but is independent of the abundant variant surface glycoprotein. Finally, we found that the protein(s) responsible for the inhibition of Plasmodium infection is/are present within a fraction of ~350 proteins that are excreted to the bloodstream of the host. We conclude that the defence mechanism developed by trypanosomes against Plasmodium relies on protein excretion. This study opens the door to the identification of novel antiplasmodial intervention strategies. Author summary Malaria and sleeping sickness are parasitic illnesses that overlap geographically, making it likely that co-infections between the two causative parasites occur. It was previously shown that when mice are first infected with Trypanosoma brucei, there was an attenuation of the subsequent infection by Plasmodium. Here we sought to assess whether an active T. brucei infection was required for this impairment, and to unravel the mechanism behind this phenomenon. We found that not only T. brucei total lysates are able to inhibit Plasmodium liver infection, but also that mice that received these lysates are partly protected from developing severe malaria pathology. We further showed that this protective effect is mediated by proteins excreted by trypanosomes. Our study paves the way to the development of novel antiplasmodial intervention strategies, based on the mechanism involved during the co-infection between T. brucei and Plasmodium.
first_indexed 2024-12-20T03:15:24Z
format Article
id doaj.art-5eaf28c1c3664433b188f94e8f25947e
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-20T03:15:24Z
publishDate 2021-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-5eaf28c1c3664433b188f94e8f25947e2022-12-21T19:55:22ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352021-10-011510Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infectionAdriana TemporãoMargarida Sanches-VazRafael LuísHelena Nunes-CabaçoTerry K. SmithMiguel PrudêncioLuisa M. FigueiredoMalaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. berghei liver infection and decreases malaria severity in mice. However, whether this effect requires an active trypanosome infection remained unknown. Here, we show that Plasmodium liver infection can also be inhibited by the serum of a mouse previously infected by T. brucei and by total protein lysates of this kinetoplastid. Biochemical characterisation showed that the anti-Plasmodium activity of the total T. brucei lysates depends on its protein fraction, but is independent of the abundant variant surface glycoprotein. Finally, we found that the protein(s) responsible for the inhibition of Plasmodium infection is/are present within a fraction of ~350 proteins that are excreted to the bloodstream of the host. We conclude that the defence mechanism developed by trypanosomes against Plasmodium relies on protein excretion. This study opens the door to the identification of novel antiplasmodial intervention strategies. Author summary Malaria and sleeping sickness are parasitic illnesses that overlap geographically, making it likely that co-infections between the two causative parasites occur. It was previously shown that when mice are first infected with Trypanosoma brucei, there was an attenuation of the subsequent infection by Plasmodium. Here we sought to assess whether an active T. brucei infection was required for this impairment, and to unravel the mechanism behind this phenomenon. We found that not only T. brucei total lysates are able to inhibit Plasmodium liver infection, but also that mice that received these lysates are partly protected from developing severe malaria pathology. We further showed that this protective effect is mediated by proteins excreted by trypanosomes. Our study paves the way to the development of novel antiplasmodial intervention strategies, based on the mechanism involved during the co-infection between T. brucei and Plasmodium.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580256/?tool=EBI
spellingShingle Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
PLoS Neglected Tropical Diseases
title Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_full Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_fullStr Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_full_unstemmed Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_short Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_sort excreted trypanosoma brucei proteins inhibit plasmodium hepatic infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580256/?tool=EBI
work_keys_str_mv AT adrianatemporao excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT margaridasanchesvaz excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT rafaelluis excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT helenanunescabaco excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT terryksmith excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT miguelprudencio excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT luisamfigueiredo excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection